☰

Todd C. Zion - Publications

Affiliations: 
Nanostructured Materials Research Laboratory - MIT 
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Alleva DG, Delpero AR, Sathiyaseelan T, Murikipudi S, Lancaster TM, Atkinson MA, Wasserfall CH, Yu L, Ragupathy R, Bonami RH, Zion TC. An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes. Frontiers in Immunology. 15: 1367514. PMID 38515750 DOI: 10.3389/fimmu.2024.1367514  0.571
2024 Alleva DG, Feitsma EA, Janssen YF, Boersma HH, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, ... ... Zion TC, et al. Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine. Npj Vaccines. 9: 40. PMID 38383578 DOI: 10.1038/s41541-024-00830-2  0.61
2023 Feitsma EA, Janssen YF, Boersma HH, van Sleen Y, van Baarle D, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, ... ... Zion TC, et al. A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452. Vaccine. PMID 36842886 DOI: 10.1016/j.vaccine.2023.02.057  0.597
2022 Hulsebosch SE, Pires J, Bannasch MJ, Lancaster T, Delpero A, Ragupathy R, Murikipudi S, Zion T, Gilor C. Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs. Journal of Veterinary Internal Medicine. PMID 35621084 DOI: 10.1111/jvim.16449  0.595
2022 Janssen YF, Feitsma EA, Boersma HH, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, ... ... Zion TC, et al. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 40: 1253-1260. PMID 35115195 DOI: 10.1016/j.vaccine.2022.01.043  0.628
2021 Alleva DG, Delpero AR, Scully MM, Murikipudi S, Ragupathy R, Greaves EK, Sathiyaseelan T, Haworth JR, Shah NJ, Rao V, Nagre S, Lancaster TM, Webb SS, Jasa AI, Ronca SE, ... ... Zion TC, et al. Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. PMID 34642088 DOI: 10.1016/j.vaccine.2021.09.077  0.603
2021 Gilor C, Hulsebosch SE, Pires J, Bannasch MJ, Lancaster T, Delpero A, Ragupathy R, Murikipudi S, Zion T. An ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in cats. Journal of Veterinary Internal Medicine. PMID 34190365 DOI: 10.1111/jvim.16150  0.588
2020 Fettig LM, Zhang X, LaPara K, Murikipudi S, Delpero AR, Lancaster TM, Zion TC, Yee D. Abstract P1-21-05: A novel long-acting insulin for cancer therapy reduces xenograft tumor growth Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P1-21-05  0.302
Show low-probability matches.